Suppliers / Chengdu Sino-Strong Pharmaceutical
Chengdu Sino-Strong Pharmaceutical
China Updated 9 July 2026
Chengdu Sino-Strong Pharmaceutical is an API manufacturer based in China. It holds 2 active US drug master files across a filed portfolio of 2 molecules.
1
registered plants
1 with an FDA FEI number
0
filings
across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Sources: FDA Establishment Registration, read 4 May 2026.
Registered plants
| Site | FDA FEI |
| China, China | 3014769475 |
What they file, and where
| Molecule | Regulators | Docs |
| Parecoxib | US FDA | 1 |
| Rocuronium | US FDA | 1 |
Also appears on these molecule pages
Comparing suppliers?
Choose your molecules and target markets. Chengdu Sino-Strong Pharmaceutical comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability